CLAIM CARD
`fact_id=187991` (`A_core`) — HBOT increased the total efficacy rate (TEF) (OR = 4.84, 95% CI = 3.19-7.33, P < 0.00001) doi=10.3389/fnagi.2019.00086
Evidence grade: exploratory
Contradiction status: none
Publication: 966edf82-6b1e-4214-8625-15d80ed50795
Provenance: Derivation Web chain
Citation Support
source_1Hyperbaric oxygen therapy increases telomere length and decreases immunosenescence in isolated blood cells : a prospective trialsource_2Efficacy of hyperbaric oxygen therapy for diabetic foot ulcer, a systematic review and meta-analysis of controlled clinical trialssource_3Meta-Analysis on the Efficacy and Safety of Hyperbaric Oxygen as Adjunctive Therapy for Vascular Dementiasource_4Potential markers of healing from near infrared spectroscopy imaging of venous leg ulcer. A randomized controlled clinical trial comparing conventional with hyperbaric oxygen treatmentsource_5Hyperbaric oxygen therapy for nonischemic diabetic ulcers: A systematic review